Following its recent announcement detailing its upcoming Netverse® platform's potential capabilities for securing clinical trials, Phinge® is highlighting how the same patented, hardware-verified technology can revolutionize research for cancer and...
Phinge Corporation, the innovator behind the upcoming patented, app-less Netverse® platform, today announced that its technology is poised to revolutionize the clinical trial landscape.
